TickerFactsScreenerDevelopers

TransMedics Group, Inc. (TMDX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2018: $7.28M2019: $9.74M2020: $9.00M2021: $9.10M2022: $28.19M2023: $87.53M2024: $179.46M2025: $242.69M$242.69M
2018Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$242.69M+35.2%
2024$179.46M+105.0%
2023$87.53M+210.5%
2022$28.19M+209.6%
2021$9.10M+1.1%
2020$9.00M-7.6%
2019$9.74M+33.7%
2018$7.28M—